108 related articles for article (PubMed ID: 7492545)
1. Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite.
Barak D; Ordentlich A; Bromberg A; Kronman C; Marcus D; Lazar A; Ariel N; Velan B; Shafferman A
Biochemistry; 1995 Nov; 34(47):15444-52. PubMed ID: 7492545
[TBL] [Abstract][Full Text] [Related]
2. Contribution of aromatic moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase.
Ordentlich A; Barak D; Kronman C; Ariel N; Segall Y; Velan B; Shafferman A
J Biol Chem; 1995 Feb; 270(5):2082-91. PubMed ID: 7836436
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core.
Barak D; Kronman C; Ordentlich A; Ariel N; Bromberg A; Marcus D; Lazar A; Velan B; Shafferman A
J Biol Chem; 1994 Mar; 269(9):6296-305. PubMed ID: 8119978
[TBL] [Abstract][Full Text] [Related]
4. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
[TBL] [Abstract][Full Text] [Related]
5. Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers.
Ordentlich A; Barak D; Kronman C; Benschop HP; De Jong LP; Ariel N; Barak R; Segall Y; Velan B; Shafferman A
Biochemistry; 1999 Mar; 38(10):3055-66. PubMed ID: 10074358
[TBL] [Abstract][Full Text] [Related]
6. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
Biochemistry; 2001 Jun; 40(25):7433-45. PubMed ID: 11412096
[TBL] [Abstract][Full Text] [Related]
7. The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
Ariel N; Ordentlich A; Barak D; Bino T; Velan B; Shafferman A
Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):95-102. PubMed ID: 9742217
[TBL] [Abstract][Full Text] [Related]
8. Stereoselectivity toward VX is determined by interactions with residues of the acyl pocket as well as of the peripheral anionic site of AChE.
Ordentlich A; Barak D; Sod-Moriah G; Kaplan D; Mizrahi D; Segall Y; Kronman C; Karton Y; Lazar A; Marcus D; Velan B; Shafferman A
Biochemistry; 2004 Sep; 43(35):11255-65. PubMed ID: 15366935
[TBL] [Abstract][Full Text] [Related]
9. The architecture of human acetylcholinesterase active center probed by interactions with selected organophosphate inhibitors.
Ordentlich A; Barak D; Kronman C; Ariel N; Segall Y; Velan B; Shafferman A
J Biol Chem; 1996 May; 271(20):11953-62. PubMed ID: 8662593
[TBL] [Abstract][Full Text] [Related]
10. The role of AChE active site gorge in determining stereoselectivity of charged and noncharged VX enantiomers.
Ordentlich A; Barak D; Sod-Moriah G; Kaplan D; Mizrahi D; Segall Y; Kronman C; Karton Y; Lazar A; Marcus D; Velan B; Shafferman A
Chem Biol Interact; 2005 Dec; 157-158():191-8. PubMed ID: 16289014
[TBL] [Abstract][Full Text] [Related]
11. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket.
Ordentlich A; Barak D; Kronman C; Flashner Y; Leitner M; Segall Y; Ariel N; Cohen S; Velan B; Shafferman A
J Biol Chem; 1993 Aug; 268(23):17083-95. PubMed ID: 8349597
[TBL] [Abstract][Full Text] [Related]
12. Functional characteristics of the oxyanion hole in human acetylcholinesterase.
Ordentlich A; Barak D; Kronman C; Ariel N; Segall Y; Velan B; Shafferman A
J Biol Chem; 1998 Jul; 273(31):19509-17. PubMed ID: 9677373
[TBL] [Abstract][Full Text] [Related]
13. Allosteric control of acetylcholinesterase catalysis by fasciculin.
Radić Z; Quinn DM; Vellom DC; Camp S; Taylor P
J Biol Chem; 1995 Sep; 270(35):20391-9. PubMed ID: 7657613
[TBL] [Abstract][Full Text] [Related]
14. Lessons from functional analysis of AChE covalent and noncovalent inhibitors for design of AD therapeutic agents.
Barak D; Ordentlich A; Kaplan D; Kronman C; Velan B; Shafferman A
Chem Biol Interact; 2005 Dec; 157-158():219-26. PubMed ID: 16289124
[TBL] [Abstract][Full Text] [Related]
15. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
Szegletes T; Mallender WD; Rosenberry TL
Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
[TBL] [Abstract][Full Text] [Related]
16. A computational study of the binding of propidium to the peripheral anionic site of human acetylcholinesterase.
Cavalli A; Bottegoni G; Raco C; De Vivo M; Recanatini M
J Med Chem; 2004 Jul; 47(16):3991-9. PubMed ID: 15267237
[TBL] [Abstract][Full Text] [Related]
17. Structural modifications of the omega loop in human acetylcholinesterase.
Velan B; Barak D; Ariel N; Leitner M; Bino T; Ordentlich A; Shafferman A
FEBS Lett; 1996 Oct; 395(1):22-8. PubMed ID: 8849682
[TBL] [Abstract][Full Text] [Related]
18. Conformers of acetylcholinesterase: a mechanism of allosteric control.
Taylor JL; Mayer RT; Himel CM
Mol Pharmacol; 1994 Jan; 45(1):74-83. PubMed ID: 8302283
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
Eichler J; Anselment A; Sussman JL; Massoulié J; Silman I
Mol Pharmacol; 1994 Feb; 45(2):335-40. PubMed ID: 8114681
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of different structure induce distinguishing conformations in the omega loop, Cys69-Cys96, of mouse acetylcholinesterase.
Shi J; Radic' Z; Taylor P
J Biol Chem; 2002 Nov; 277(45):43301-8. PubMed ID: 12196517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
